Schedule 13G ownership disclosure
CONSTELLATION PHARMACEUTICALS INC
Security class unavailable · CUSIP: 210373106
Event date: 2018-07-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000897069-18-000476
- Form type
- SC 13G
- Filer
- CONSTELLATION PHARMACEUTICALS INC
- CIK
- CIK 1434418
- Filed
- Jul 25, 2018
- Reporting period
- Jul 18, 2018
- Description
- Schedule 13G beneficial ownership